BIOMAT Database Logo BIOMAT Database Logo

High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome. 1995

A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology, Italy.

We report the effects of treatment with plasma-exchange (PE) and intravenous immune globulins (IVIg) in 36 out of 50 patients with Guillain-Barré syndrome (GBS) recruited by an incidence study in the Emilia-Romagna region of Italy. Comparison of the patients treated with PE and IVIg showed no significant differences in terms of effectiveness in improving the clinical course of GBS: at one month, respectively 11.1% and 25% had recovered, and 55.5% and 58.3% had improved by at least one grade. These results are in agreement with those of the Dutch GBS trial. No relapses were observed in either group. Moreover, our results showed no difference in clinical outcome at 1 and 3 months between the patients receiving only one therapy and those receiving two; a second cycle of therapy did not seem to improve the clinical course of the disease significantly. We conclude that PE and IVIg are both safe and effective therapies for GBS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immune globulins in Guillain-Barré syndrome in pregnancy.
January 1998, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
[A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
June 1997, Rinsho shinkeigaku = Clinical neurology,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
September 1992, The New England journal of medicine,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
September 1992, The New England journal of medicine,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 days.
August 2001, Journal of neurology, neurosurgery, and psychiatry,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
December 1993, Neurology,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
December 1993, Neurology,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
[Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
June 1993, Rinsho shinkeigaku = Clinical neurology,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
April 1992, The New England journal of medicine,
A Ravasio, and M Pasquinelli, and B Currò Dossi, and W Neri, and C Guidi, and M Gessaroli, and F Rasi, and R Fabbri, and G Mazzini, and G G Rebucci
High-dose intravenous gammaglobulin in Guillain-Barré syndrome.
October 1988, Annals of neurology,
Copied contents to your clipboard!